Eli Lilly invests to increase Mounjaro and Zepbound offering
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
pharmaceutical products
This promising cancer treatment could represent a $25 billion market opportunity
Skynesher | E+ | fake images Big Pharma is betting billions on a promising class of cancer treatments that some…
Stocks set to move as this corner of the cancer therapy market heats up
Much attention has been paid lately to a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy…
Pfizer announces new cost reduction program
Exterior view of the Pfizer headquarters building in New York City on January 29, 2023. Kena Betancur | Corbis News…
Eli Lilly shares hit new highs after a regulatory victory in China. This is a big problem
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
FDA approves Amgen's small cell lung cancer treatment
Amgen's headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | fake images The Food and Drug Administration on Thursday…
Roche's weight-loss drug shows promising results in early trial
A logo at the headquarters of Roche Holding AG in Basel, Switzerland, Thursday, February 1, 2024. Bloomberg | fake images…
Walgreens to Offer Cheaper Medications for Opioid Overdoses
A person walks past a Walgreens truck, owned by Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26,…
Wegovy Patients Maintain Weight Loss for 4 Years: Novo Nordisk Study
Boxes of Wegovy manufactured by Novo Nordisk in a pharmacy in London, Britain, on March 8, 2024. Hollie Adams |…
Novavax shares rise after Sanofi Covid vaccine deal
In this illustration taken on January 16, 2022, a vial labeled “Novavax V COVID-19 Vaccine” is seen. Ruvic Dice |…